海欣股份：控股子公司药品通过仿制药一致性评价

Core Viewpoint - The company HaiXin Co., Ltd. has received approval from the National Medical Products Administration for its generic drug "Vitamin B6 Injection," which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Company Summary - HaiXin Co., Ltd. announced on December 26 that its subsidiary Jiangxi Gannan HaiXin Pharmaceutical Co., Ltd. has obtained the approval notice for the supplemental application of the chemical drug "Vitamin B6 Injection" [1] - The approval indicates that the drug meets the required standards for quality and efficacy, which is crucial for its market entry and competitiveness [1]